Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Ordinary shares, nominal value 0.0025 per share
-
Shares outstanding
-
328,915,843
-
Total 13F shares
-
409,311
-
Share change
-
-220,990
-
Total reported value
-
$2,246,000
-
Price per share
-
$5.49
-
Number of holders
-
3
-
Value change
-
-$1,181,467
-
Number of sells
-
2
Institutional Holders of Renalytix plc - Ordinary shares, nominal value 0.0025 per share as of Q3 2020
As of 30 Sep 2020,
Renalytix plc - Ordinary shares, nominal value 0.0025 per share was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
409,311 shares.
The largest 3 holders included
GILDER GAGNON HOWE & CO LLC, TIAA, FSB, and GOFEN & GLOSSBERG LLC /IL/.
This page lists
3
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.